2024
DOI: 10.1016/j.cjca.2023.11.009
|View full text |Cite
|
Sign up to set email alerts
|

Advances in Hypertrophic Cardiomyopathy Disease Modelling Using hiPSC-Derived Cardiomyocytes

Saif Dababneh,
Homa Hamledari,
Yasaman Maaref
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 92 publications
0
0
0
Order By: Relevance
“…To differentiate hiPSCs into cardiomyocytes in following our previously published protocol [41][42] [24], hiPSCs were seeded on a six-well plate coated with Matrigel (0.5 mg/six-well plate, dissolved in DMEM/F-12 medium) in mTeSR Plus medium (StemCell Technologies, Vancouver, BC, Canada). Once reaching 60% confluency, the mTeSR medium was replaced with Roswell Park Memorial Institute Medium (RPMI) 1640 supplemented with 2% B27 (-insulin) and 7.5 μM CHIR99021 for 48 hours.…”
Section: D Hipsc Differentiation To Cmsmentioning
confidence: 99%
“…To differentiate hiPSCs into cardiomyocytes in following our previously published protocol [41][42] [24], hiPSCs were seeded on a six-well plate coated with Matrigel (0.5 mg/six-well plate, dissolved in DMEM/F-12 medium) in mTeSR Plus medium (StemCell Technologies, Vancouver, BC, Canada). Once reaching 60% confluency, the mTeSR medium was replaced with Roswell Park Memorial Institute Medium (RPMI) 1640 supplemented with 2% B27 (-insulin) and 7.5 μM CHIR99021 for 48 hours.…”
Section: D Hipsc Differentiation To Cmsmentioning
confidence: 99%